Basics Fulcrum Therapeutics, Inc. IPO Date: July 15, 2019 Sector: Healthcare Industry: Biotech Market Cap: $342.77M Activated in VL: True Average Daily Range Avg Daily Range: $0.39 | 4.01% Avg Daily Range (30 D): $0.26 | 5.38% Avg Daily Range (90 D): $0.16 | 3.98% Institutional Daily Volume Avg Daily Volume: .62M Avg Daily Volume (30 D): .66M Avg Daily Volume (90 D): .44M Trade Size Avg Trade Size (Sh.): 110 Avg Trade Size (Sh.) (30 D): 91 Avg Trade Size (Sh.) (90 D): 87 Institutional Trades Total Inst.Trades: 615 Avg Inst. Trade: $1.55M Avg Inst. Trade (30 D): $.83M Avg Inst. Trade (90 D): $1.01M Avg Inst. Trade Volume: .18M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.6M Avg Closing Trade (30 D): $.9M Avg Closing Trade (90 D): $1.12M Avg Closing Volume: 180.59K         News Feb 7, 2025 @ 9:30 PM Fulcrum Therapeutics Reports Inducement Grants Und... Source: N/A Nov 6, 2024 @ 1:00 PM Fulcrum Therapeutics to Host Third Quarter 2024 Fi... Source: N/A Oct 11, 2024 @ 8:30 PM Fulcrum Therapeutics Reports Inducement Grants Und... Source: N/A Sep 24, 2024 @ 7:08 PM BHVN Stock Up as Rare Neurological Disease Study M... Source: Zacks Sep 19, 2024 @ 8:00 PM FULC INVESTOR ALERT: Bronstein, Gewirtz and Grossm... Source: Bronstein, Gewirtz & Grossman, Llc Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.01 $-.28 $-.27 Diluted EPS $-.03 $-.28 $-.27 Revenue $ 80M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -.51M $ -17.66M $ -16.57M Operating Income / Loss $ -12.47M $ -20.4M $ -19.43M Cost of Revenue $ $ $ Net Cash Flow $ 18.26M $ M $ -14.42M PE Ratio